2024 Q2 Form 10-Q Financial Statement

#000170471524000097 Filed on May 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $804.0M $864.1M
YoY Change -6.34% -5.18%
Cost Of Revenue $663.8M $648.3M
YoY Change 13.76% 20.25%
Gross Profit $140.2M $215.8M
YoY Change -49.01% -42.02%
Gross Profit Margin 17.43% 24.97%
Selling, General & Admin $18.81M $22.38M
YoY Change 7.42% 8.14%
% of Gross Profit 13.42% 10.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $43.38M $40.70M
YoY Change 26.04% 38.33%
% of Gross Profit 30.95% 18.86%
Operating Expenses $18.81M $22.38M
YoY Change -66.87% 8.14%
Operating Profit $70.68M $141.9M
YoY Change -67.6% -54.89%
Interest Expense -$2.878M $1.086M
YoY Change 26.45% -36.86%
% of Operating Profit -4.07% 0.77%
Other Income/Expense, Net -$6.489M -$718.0K
YoY Change 642.45% -45.56%
Pretax Income $64.19M $141.2M
YoY Change -70.14% -54.93%
Income Tax $5.278M $14.17M
% Of Pretax Income 8.22% 10.03%
Net Earnings $58.91M $127.0M
YoY Change -67.52% -53.1%
Net Earnings / Revenue 7.33% 14.7%
Basic Earnings Per Share $4.53 $9.77
Diluted Earnings Per Share $4.49 $9.59
COMMON SHARES
Basic Shares Outstanding 13.01M shares 12.99M shares
Diluted Shares Outstanding 13.11M shares 13.24M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $336.1M $269.4M
YoY Change 7.6% 21.07%
Cash & Equivalents $336.1M $269.4M
Short-Term Investments
Other Short-Term Assets $32.87M $34.87M
YoY Change -48.19% -38.88%
Inventory $221.8M $246.0M
Prepaid Expenses
Receivables $505.1M $526.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.096B $1.077B
YoY Change 1.63% -1.46%
LONG-TERM ASSETS
Property, Plant & Equipment $1.075B $1.058B
YoY Change 11.08% 11.92%
Goodwill
YoY Change
Intangibles $43.23M $44.90M
YoY Change -14.76% -15.12%
Long-Term Investments
YoY Change
Other Assets $109.4M $113.6M
YoY Change -58.18% 6.21%
Total Long-Term Assets $1.397B $1.384B
YoY Change 9.18% 10.16%
TOTAL ASSETS
Total Short-Term Assets $1.096B $1.077B
Total Long-Term Assets $1.397B $1.384B
Total Assets $2.493B $2.461B
YoY Change 5.73% 4.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $122.5M $151.5M
YoY Change 15.35% 23.4%
Accrued Expenses $121.5M $124.2M
YoY Change 6.67% 12.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.263M $3.392M
YoY Change -6.4% -4.77%
Total Short-Term Liabilities $308.7M $341.3M
YoY Change 4.37% 7.8%
LONG-TERM LIABILITIES
Long-Term Debt $5.301M $6.034M
YoY Change -31.7% -27.99%
Other Long-Term Liabilities $21.12M $20.54M
YoY Change -95.35% 10.92%
Total Long-Term Liabilities $21.12M $20.54M
YoY Change -95.43% 10.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $308.7M $341.3M
Total Long-Term Liabilities $21.12M $20.54M
Total Liabilities $849.4M $869.7M
YoY Change 7.37% 8.63%
SHAREHOLDERS EQUITY
Retained Earnings $2.155B $2.096B
YoY Change 25.76% 36.16%
Common Stock $224.0K $224.0K
YoY Change 2.28% 2.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.644B $1.591B
YoY Change
Total Liabilities & Shareholders Equity $2.493B $2.461B
YoY Change 5.73% 4.75%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $58.91M $127.0M
YoY Change -67.52% -53.1%
Depreciation, Depletion And Amortization $43.38M $40.70M
YoY Change 26.04% 38.33%
Cash From Operating Activities $138.1M $196.1M
YoY Change -56.46% 10.53%
INVESTING ACTIVITIES
Capital Expenditures $61.10M $63.62M
YoY Change 11.37% -14.32%
Acquisitions
YoY Change
Other Investing Activities -$10.57M -$6.000K
YoY Change -192.31% -50.0%
Cash From Investing Activities -$71.67M -$68.86M
YoY Change 65.1% 146.89%
FINANCING ACTIVITIES
Cash Dividend Paid $3.000M
YoY Change -96.51%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $632.0K
YoY Change 44.29%
Cash From Financing Activities -2.511M -$120.0M
YoY Change -98.46% -48.14%
NET CHANGE
Cash From Operating Activities 138.1M $196.1M
Cash From Investing Activities -71.67M -$68.86M
Cash From Financing Activities -2.511M -$120.0M
Net Change In Cash 63.94M $7.188M
YoY Change -42.01% -108.77%
FREE CASH FLOW
Cash From Operating Activities $138.1M $196.1M
Capital Expenditures $61.10M $63.62M
Free Cash Flow $77.03M $132.5M
YoY Change -70.64% 28.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Other Income
OtherIncome
2789000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
4537000 usd
CY2024Q1 us-gaap Revenues
Revenues
864072000 usd
CY2023Q1 us-gaap Revenues
Revenues
911235000 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
648313000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
539137000 usd
CY2024Q1 amr Depreciation Depletion And Amortization Excluding Acquired Intangibles
DepreciationDepletionAndAmortizationExcludingAcquiredIntangibles
40701000 usd
CY2023Q1 amr Depreciation Depletion And Amortization Excluding Acquired Intangibles
DepreciationDepletionAndAmortizationExcludingAcquiredIntangibles
29423000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6143000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6377000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1675000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2197000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1048297000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
588735000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22377000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20692000 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2985000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1092000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
722194000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
596734000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
141878000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
314501000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1086000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1720000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3971000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1518000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1640000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1748000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1963000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
631000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-718000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1319000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
141160000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
313182000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14165000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42411000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
126995000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
270771000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.77
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
17.74
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.59
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
17.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13002127 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15266895 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13236596 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15916378 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
126995000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
270771000 usd
CY2024Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-964000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
627000 usd
CY2024Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-214000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
139000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
750000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-488000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
127745000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
270283000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
269386000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
268207000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
217000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
234000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
526222000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
509682000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
246033000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
231344000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
34868000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39064000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1076509000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
558905000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
607637000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
588992000 usd
CY2024Q1 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
106429000 usd
CY2023Q4 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
99826000 usd
CY2024Q1 us-gaap Mineral Rights
MineralRights
449892000 usd
CY2023Q4 us-gaap Mineral Rights
MineralRights
451160000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
40218000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38543000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
44904000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46579000 usd
CY2024Q1 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
38055000 usd
CY2023Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
40597000 usd
CY2024Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
121927000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
115918000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8284000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8028000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
113601000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106486000 usd
CY2024Q1 us-gaap Assets
Assets
2460809000 usd
CY2023Q4 us-gaap Assets
Assets
2406057000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3392000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3582000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
151453000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
128836000 usd
CY2024Q1 amr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
186444000 usd
CY2023Q4 amr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
177512000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
341289000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
309930000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6034000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6792000 usd
CY2024Q1 amr Liability Defined Benefit Plan Postretirement Black Lung Health Coverage And Workers Compensation Noncurrent
LiabilityDefinedBenefitPlanPostretirementBlackLungHealthCoverageAndWorkersCompensationNoncurrent
186023000 usd
CY2023Q4 amr Liability Defined Benefit Plan Postretirement Black Lung Health Coverage And Workers Compensation Noncurrent
LiabilityDefinedBenefitPlanPostretirementBlackLungHealthCoverageAndWorkersCompensationNoncurrent
189226000 usd
CY2024Q1 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
101800000 usd
CY2023Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
101908000 usd
CY2024Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
172758000 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
166509000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
41226000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
39142000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20535000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18622000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
869665000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
832129000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22371165 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13007215 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22058135 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12938679 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
224000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
221000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
830536000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
834482000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39837000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-40587000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9363950 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9119456 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1295639000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1189715000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2095860000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1969527000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1591144000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1573928000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2460809000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2406057000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
126995000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
270771000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40701000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29423000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1675000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2197000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
280000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
534000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1610000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2363000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6143000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6377000 usd
CY2024Q1 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
3833000 usd
CY2023Q1 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
3261000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1614000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14432000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2769000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3034000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1640000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1748000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-197000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
126000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-9011000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
152153000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
196074000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
177387000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
63618000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
74248000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
287000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
3478000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
11919000 usd
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7230000 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
141750000 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
10172000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
204660000 usd
CY2024Q1 amr Payments To Acquire Equity Method Investments Capital Contributions
PaymentsToAcquireEquityMethodInvestmentsCapitalContributions
8476000 usd
CY2023Q1 amr Payments To Acquire Equity Method Investments Capital Contributions
PaymentsToAcquireEquityMethodInvestmentsCapitalContributions
8124000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-6000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-12000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68859000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27891000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
632000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
438000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
3000000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
85979000 usd
CY2024Q1 amr Payments For Repurchase Of Common Stock And Related Expenses
PaymentsForRepurchaseOfCommonStockAndRelatedExpenses
116089000 usd
CY2023Q1 amr Payments For Repurchase Of Common Stock And Related Expenses
PaymentsForRepurchaseOfCommonStockAndRelatedExpenses
144919000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-306000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-116000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-120027000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-231452000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7188000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-81956000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
384125000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355394000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
391313000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273438000 usd
CY2024Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 usd
CY2023Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1753000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
14525000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13703000 usd
CY2024Q1 amr Accrued Common Stock Repurchases And Stock Repurchase Excise Tax
AccruedCommonStockRepurchasesAndStockRepurchaseExciseTax
4665000 usd
CY2023Q1 amr Accrued Common Stock Repurchases And Stock Repurchase Excise Tax
AccruedCommonStockRepurchasesAndStockRepurchaseExciseTax
5995000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
525000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
8973000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
269386000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
222507000 usd
CY2024Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
121927000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
50931000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
391313000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273438000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1429755000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
270771000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-488000 usd
CY2023Q1 amr Share Based Compensation Issuance Of Stock For Share Vesting And Stock Reissuance
ShareBasedCompensationIssuanceOfStockForShareVestingAndStockReissuance
3034000 usd
CY2023Q1 amr Treasury Stock Value Acquired Cost Method And Related Expenses
TreasuryStockValueAcquiredCostMethodAndRelatedExpenses
148973000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1301000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6825000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1548575000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1573928000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
126995000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
750000 usd
CY2024Q1 amr Share Based Compensation Issuance Of Stock For Share Vesting And Stock Reissuance
ShareBasedCompensationIssuanceOfStockForShareVestingAndStockReissuance
2769000 usd
CY2024Q1 amr Treasury Stock Value Acquired Cost Method And Related Expenses
TreasuryStockValueAcquiredCostMethodAndRelatedExpenses
112636000 usd
CY2024Q1 amr Dividend Equivalents
DividendEquivalents
662000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1591144000 usd
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For comparability purposes, certain immaterial segment information for the three months ended March 31, 2023 in the notes to the Condensed Consolidated Financials Statements has been recast to conform to the current year presentation. Refer to Note 15.</span></div>
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
85016000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
85016000 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
126995000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
270771000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13002127 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15266895 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.77
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
17.74
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13002127 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15266895 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
158304 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13236596 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15916378 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.59
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
17.01
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
51602000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
52508000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
130071000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
120000000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
64360000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
58836000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
246033000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
231344000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1500000000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
6630535 shares
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1098916000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1098717000 usd
amr Stock Repurchase Program Expenses
StockRepurchaseProgramExpenses
199000 usd
CY2024Q1 amr Stock Repurchase Program Excise Tax
StockRepurchaseProgramExciseTax
4665000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
59867000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62811000 usd
CY2024Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
10467000 usd
CY2023Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
10482000 usd
CY2024Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
10687000 usd
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
10687000 usd
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
31998000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
31236000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
38713000 usd
CY2023Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
38915000 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
427000 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
2342000 usd
CY2024Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
5050000 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 usd
CY2024Q1 amr Accrued Transportation Costs Current
AccruedTransportationCostsCurrent
21837000 usd
CY2023Q4 amr Accrued Transportation Costs Current
AccruedTransportationCostsCurrent
8461000 usd
CY2024Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
7398000 usd
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
12578000 usd
CY2024Q1 amr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
186444000 usd
CY2023Q4 amr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
177512000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
4456000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
5097000 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
4970000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
5277000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
9426000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
10374000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3392000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3582000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6034000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6792000 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
205424000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6143000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
5381000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-79000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
5556000 usd
CY2024Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
211471000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
38713000 usd
CY2024Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
172758000 usd
CY2023Q4 us-gaap Restricted Investments
RestrictedInvestments
40597000 usd
CY2024Q1 us-gaap Deposit Assets
DepositAssets
5347000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14165000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
141160000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42411000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
313182000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
121927000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
115918000 usd
CY2024Q1 us-gaap Restricted Investments
RestrictedInvestments
38055000 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
5382000 usd
CY2024Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
0 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
32000 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
5347000 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
5350000 usd
CY2024Q1 us-gaap Revenues
Revenues
864072000 usd
CY2023Q1 us-gaap Revenues
Revenues
911235000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
126995000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
270771000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1086000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1720000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3971000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1518000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14165000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42411000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40701000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29423000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2769000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3034000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6143000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6377000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1675000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2197000 usd
CY2024Q1 amr Adjusted Earnings Before Income Tax Interest Depreciation And Amortization
AdjustedEarningsBeforeIncomeTaxInterestDepreciationAndAmortization
189563000 usd
CY2023Q1 amr Adjusted Earnings Before Income Tax Interest Depreciation And Amortization
AdjustedEarningsBeforeIncomeTaxInterestDepreciationAndAmortization
354415000 usd
CY2024Q1 amr Adjusted Earnings Before Income Tax Interest Depreciation And Amortization
AdjustedEarningsBeforeIncomeTaxInterestDepreciationAndAmortization
189563000 usd
CY2023Q1 amr Adjusted Earnings Before Income Tax Interest Depreciation And Amortization
AdjustedEarningsBeforeIncomeTaxInterestDepreciationAndAmortization
354415000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
861283000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
906698000 usd
CY2024Q1 us-gaap Revenues
Revenues
864072000 usd
CY2023Q1 us-gaap Revenues
Revenues
911235000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001704715-24-000097-index-headers.html Edgar Link pending
0001704715-24-000097-index.html Edgar Link pending
0001704715-24-000097.txt Edgar Link pending
0001704715-24-000097-xbrl.zip Edgar Link pending
a3312024exhibit31.htm Edgar Link pending
a3312024exhibit32.htm Edgar Link pending
a3312024exhibit95.htm Edgar Link pending
amr-20240331.htm Edgar Link pending
amr-20240331.xsd Edgar Link pending
amr-20240331_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
amr-20240331_cal.xml Edgar Link unprocessable
amr-20240331_def.xml Edgar Link unprocessable
amr-20240331_lab.xml Edgar Link unprocessable
amr-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
amr-20240331_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending